Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83


Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation.

Colombani T, Haudebourg T, Decossas M, Lambert O, Ada Da Silva G, Altare F, Pitard B.

Adv Sci (Weinh). 2019 Jul 15;6(16):1900288. doi: 10.1002/advs.201900288. eCollection 2019 Aug 21.


Interaction of mycobacteria with Plasmin(ogen) affects phagocytosis and granuloma development.

Echeverría-Valencia G, Silva-Miranda M, Ekaza E, Vallecillo AJ, Parada C, Sada-Ovalle I, Altare F, Espitia C.

Tuberculosis (Edinb). 2019 Jul;117:36-44. doi: 10.1016/ Epub 2019 Jun 1.


Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction.

Alameddine J, Godefroy E, Papargyris L, Sarrabayrouse G, Tabiasco J, Bridonneau C, Yazdanbakhsh K, Sokol H, Altare F, Jotereau F.

Front Immunol. 2019 Feb 6;10:143. doi: 10.3389/fimmu.2019.00143. eCollection 2019.


Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia.

Ruggeri T, Jacqueline C, Ambrosi X, Broquet A, Desfrançois J, Roquilly A, Altare F, Asehnoune K.

Crit Care Med. 2019 Jan;47(1):e28-e35. doi: 10.1097/CCM.0000000000003466.


Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.

Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, Altare F.

Gastroenterology. 2018 Oct;155(4):1205-1217. doi: 10.1053/j.gastro.2018.06.078. Epub 2018 Jul 5.


Immune discrepancies during in vitro granuloma formation in response to Cutibacterium (formerly Propionibacterium) acnes infection.

Aubin GG, Ada Da Silva G, Eishi Y, Jacqueline C, Altare F, Corvec S, Asehnoune K.

Anaerobe. 2017 Dec;48:172-176. doi: 10.1016/j.anaerobe.2017.08.014. Epub 2017 Aug 30.


Healthy caregivers-healthy children (HC2) phase 2: Integrating culturally sensitive childhood obesity prevention strategies into childcare center policies.

Messiah SE, Lebron C, Moise R, Sunil Mathew M, Sardinas K, Chang C, Palenzuela J, Walsh J, Shelnutt KP, Spector R, Altare F, Natale R.

Contemp Clin Trials. 2017 Feb;53:60-67. doi: 10.1016/j.cct.2016.12.011. Epub 2016 Dec 12.


Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin).

Breiman A, López Robles MD, de Carné Trécesson S, Echasserieau K, Bernardeau K, Drickamer K, Imberty A, Barillé-Nion S, Altare F, Le Pendu J.

Oncotarget. 2016 Mar 22;7(12):14064-82. doi: 10.18632/oncotarget.7476.


FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.

Marion E, Jarry U, Cano C, Savary C, Beauvillain C, Robbe-Saule M, Preisser L, Altare F, Delneste Y, Jeannin P, Marsollier L.

J Immunol. 2016 Mar 15;196(6):2690-8. doi: 10.4049/jimmunol.1502194. Epub 2016 Feb 12.


Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD.

Sarrabayrouse G, Alameddine J, Altare F, Jotereau F.

Front Immunol. 2015 Oct 8;6:522. doi: 10.3389/fimmu.2015.00522. eCollection 2015. Review.


High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.

Silva-Miranda M, Ekaza E, Breiman A, Asehnoune K, Barros-Aguirre D, Pethe K, Ewann F, Brodin P, Ballell-Pages L, Altare F.

Antimicrob Agents Chemother. 2015 Jan;59(1):693-7. doi: 10.1128/AAC.03705-14. Epub 2014 Oct 27.


Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage.

Roquilly A, Broquet A, Jacqueline C, Masson D, Segain JP, Braudeau C, Vourc'h M, Caillon J, Altare F, Josien R, Retière C, Villadangos J, Asehnoune K.

Crit Care Med. 2014 Dec;42(12):e752-61. doi: 10.1097/CCM.0000000000000658.


CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F.

PLoS Biol. 2014 Apr 8;12(4):e1001833. doi: 10.1371/journal.pbio.1001833. eCollection 2014 Apr.


Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.

Jacqueline C, Broquet A, Roquilly A, Davieau M, Caillon J, Altare F, Potel G, Asehnoune K.

J Infect Dis. 2014 Sep 1;210(5):814-23. doi: 10.1093/infdis/jiu145. Epub 2014 Mar 11.


Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice.

Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, Djouina M, Deknuydt F, Atrott K, Esquerre N, Altare F, Neut C, Arrieta MC, Kanneganti TD, Rogler G, Colombel JF, Cortot A, Desreumaux P, Vignal C.

Mucosal Immunol. 2014 May;7(3):589-601. doi: 10.1038/mi.2013.78. Epub 2013 Oct 16.


Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.

Ekaza E, N'Guessan RK, Kacou-N'Douba A, Aka N, Kouakou J, Le Vacon F, Altare F, Potel G, de-La-Cochetiere MF.

Biomed Res Int. 2013;2013:426709. doi: 10.1155/2013/426709. Epub 2013 Sep 4. Review.


Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells.

Roquilly A, Broquet A, Jacqueline C, Gautreau L, Segain JP, de Coppet P, Caillon J, Altare F, Josien R, Asehnoune K.

Eur Respir J. 2013 Nov;42(5):1365-78. doi: 10.1183/09031936.00152612. Epub 2013 Jan 11.


An in vitro model of mycobacterial granuloma to investigate the immune response in brain-injured patients.

Deknuydt F, Roquilly A, Cinotti R, Altare F, Asehnoune K.

Crit Care Med. 2013 Jan;41(1):245-54. doi: 10.1097/CCM.0b013e3182676052.


The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?

Silva Miranda M, Breiman A, Allain S, Deknuydt F, Altare F.

Clin Dev Immunol. 2012;2012:139127. doi: 10.1155/2012/139127. Epub 2012 Jul 3. Review.


First human model of in vitro Candida albicans persistence within granuloma for the reliable study of host-fungi interactions.

Alvarez-Rueda N, Albassier M, Allain S, Deknuydt F, Altare F, Le Pape P.

PLoS One. 2012;7(6):e40185. doi: 10.1371/journal.pone.0040185. Epub 2012 Jun 29.


Comparison of the moonlighting actions of the two highly homologous chaperonin 60 proteins of Mycobacterium tuberculosis.

Cehovin A, Coates AR, Hu Y, Riffo-Vasquez Y, Tormay P, Botanch C, Altare F, Henderson B.

Infect Immun. 2010 Jul;78(7):3196-206. doi: 10.1128/IAI.01379-09. Epub 2010 Apr 26.


Foamy macrophages and the progression of the human tuberculosis granuloma.

Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F.

Nat Immunol. 2009 Sep;10(9):943-8. doi: 10.1038/ni.1781. Epub 2009 Aug 19. Review.


FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.

Taflin C, Miyara M, Nochy D, Valeyre D, Naccache JM, Altare F, Salek-Peyron P, Badoual C, Bruneval P, Haroche J, Mathian A, Amoura Z, Hill G, Gorochov G.

Am J Pathol. 2009 Feb;174(2):497-508. doi: 10.2353/ajpath.2009.080580. Epub 2009 Jan 15.


Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models.

Cáceres N, Tapia G, Ojanguren I, Altare F, Gil O, Pinto S, Vilaplana C, Cardona PJ.

Tuberculosis (Edinb). 2009 Mar;89(2):175-82. doi: 10.1016/ Epub 2008 Dec 24.


Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence.

Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F.

PLoS Pathog. 2008 Nov;4(11):e1000204. doi: 10.1371/journal.ppat.1000204. Epub 2008 Nov 11.


Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and beta1 integrin-mediated pathway.

Puissegur MP, Lay G, Gilleron M, Botella L, Nigou J, Marrakchi H, Mari B, Duteyrat JL, Guerardel Y, Kremer L, Barbry P, Puzo G, Altare F.

J Immunol. 2007 Mar 1;178(5):3161-9.


Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro.

Meconi S, Vercellone A, Levillain F, Payré B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F.

Cell Microbiol. 2007 May;9(5):1252-61. Epub 2007 Jan 11.


Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake.

Lay G, Poquet Y, Salek-Peyron P, Puissegur MP, Botanch C, Bon H, Levillain F, Duteyrat JL, Emile JF, Altare F.

J Pathol. 2007 Jan;211(1):76-85.


Hypothalamo-hypophysial dysfunction after traumatic brain injury in children and adolescents: a preliminary retrospective and prospective study.

Einaudi S, Matarazzo P, Peretta P, Grossetti R, Giordano F, Altare F, Bondone C, Andreo M, Ivani G, Genitori L, de Sanctis C.

J Pediatr Endocrinol Metab. 2006 May;19(5):691-703.


McCune-Albright syndrome: persistence of autonomous ovarian hyperfunction during adolescence and early adult age.

Matarazzo P, Lala R, Andreo M, Einaudi S, Altare F, Viora E, Buzi F, De Luca F, De Sanctis V, Rigon F, Wasniewska M, de Sanctis L, de Sanctis C; Study Group for Gs alpha Protein Related Diseases of the Italian Society for Pediatric Endocrinology and Diabetes.

J Pediatr Endocrinol Metab. 2006 May;19 Suppl 2:607-17.


Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.

Saracco P, Bertorello N, Farinasso L, Einaudi S, Barisone E, Altare F, Corrias A, Pastore G.

J Pediatr Hematol Oncol. 2005 Mar;27(3):141-4. Erratum in: J Pediatr Hematol Oncol. 2005 Apr;27(4):242. Corrias, Andrea [added].


A high neonatal serum eosinophil cationic protein level is a risk factor for atopic symptoms.

Monti G, Peltran A, Coscia A, Bertino E, Ferrero L, Savant-Levet P, Guala G, Altare F, Russo R, Fabris C.

Acta Paediatr. 2004 Jun;93(6):765-9.


An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells.

Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F.

Cell Microbiol. 2004 May;6(5):423-33.


Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.

Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Da Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhöft J, Cleary AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist CA, Ehlayel MS, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL.

J Exp Med. 2003 Feb 17;197(4):527-35.


IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.

Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.

J Leukoc Biol. 2002 Oct;72(4):735-42.


Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.

Matarazzo P, Lala R, Masi G, Andreo M, Altare F, de Sanctis C.

J Pediatr Endocrinol Metab. 2002;15 Suppl 3:929-37.


Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells.

Losana G, Rigamonti L, Borghi I, Assenzio B, Ariotti S, Jouanguy E, Altare F, Forni G, Casanova JL, Novelli F.

Eur J Immunol. 2002 Mar;32(3):693-700.


Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.

Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, Dupuis S, Soudais C, Al-Mohsen IZ, Génin E, Lammas D, Kumararatne DS, Leclerc T, Rafii A, Frayha H, Murugasu B, Wah LB, Sinniah R, Loubser M, Okamoto E, Al-Ghonaium A, Tufenkeji H, Abel L, Casanova JL.

Am J Hum Genet. 2002 Feb;70(2):336-48. Epub 2001 Dec 17.


Effect of conjugated estrogens on free IGF-I?

Campagnoli C, Altare F, Buzio C, Sanseverino P.

Fertil Steril. 2001 Sep;76(3):640-1. No abstract available.


Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols.

Corrias A, Einaudi S, Ricardi U, Sandri A, Besenzon L, Altare F, Artesani L, Genitori L, Andreo M, De Sanctis C.

J Endocrinol Invest. 2001 Jun;24(6):387-92.


Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis.

Altare F, Ensser A, Breiman A, Reichenbach J, Baghdadi JE, Fischer A, Emile JF, Gaillard JL, Meinl E, Casanova JL.

J Infect Dis. 2001 Jul 15;184(2):231-6. Epub 2001 Jun 14.


Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency.

Aksu G, Tirpan C, Cavuşoğlu C, Soydan S, Altare F, Casanova JL, Kutukculer N.

Pediatr Infect Dis J. 2001 May;20(5):551-3.


Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.

Dupuis S, Döffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, Abel L, Casanova JL.

Immunol Rev. 2000 Dec;178:129-37. Review.


Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.

Döffinger R, Altare F, Casanova JL.

Microbes Infect. 2000 Nov;2(13):1553-7. Review.


Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections.

Gollob JA, Veenstra KG, Jyonouchi H, Kelly AM, Ferrieri P, Panka DJ, Altare F, Fieschi C, Casanova JL, Frank DA, Mier JW.

J Immunol. 2000 Oct 1;165(7):4120-6.


In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.

Jouanguy E, Dupuis S, Pallier A, Döffinger R, Fondanèche MC, Fieschi C, Lamhamedi-Cherradi S, Altare F, Emile JF, Lutz P, Bordigoni P, Cokugras H, Akcakaya N, Landman-Parker J, Donnadieu J, Camcioglu Y, Casanova JL.

J Clin Invest. 2000 May;105(10):1429-36.


Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection.

Döffinger R, Jouanguy E, Dupuis S, Fondanèche MC, Stephan JL, Emile JF, Lamhamedi-Cherradi S, Altare F, Pallier A, Barcenas-Morales G, Meinl E, Krause C, Pestka S, Schreiber RD, Novelli F, Casanova JL.

J Infect Dis. 2000 Jan;181(1):379-84.


Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man.

Döffinger R, Jouanguy E, Altare F, Wood P, Shirakawa T, Novelli F, Lammas D, Kumararatne D, Casanova JL.

Allergy. 1999 May;54(5):409-12. Review. No abstract available.


IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.

Jouanguy E, Döffinger R, Dupuis S, Pallier A, Altare F, Casanova JL.

Curr Opin Immunol. 1999 Jun;11(3):346-51. Review.


A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection.

Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondanèche MC, Dupuis S, Döffinger R, Altare F, Girdlestone J, Emile JF, Ducoulombier H, Edgar D, Clarke J, Oxelius VA, Brai M, Novelli V, Heyne K, Fischer A, Holland SM, Kumararatne DS, Schreiber RD, Casanova JL.

Nat Genet. 1999 Apr;21(4):370-8.


Supplemental Content

Loading ...
Support Center